A305 ERYTHROMYCIN AND RELATED MACROLIDES FOR GASTROPARESIS
Bibliographic record
Abstract
Gastroparesis is a chronic functional gastrointestinal disorder with considerable morbidity, caused by the failure of the stomach to pump its contents in the absence of a mechanical obstruction, and characterized by symptoms related to impaired gastric emptying. Erythromycin is a macrolide antibiotic that is known to have motilin receptor agonist activity. Having an effect similar to that of motilin, erythromycin has been shown to raise the amplitude of antral peristalsis and initiate premature migrating motor complex phase III activity, thereby stimulating gastric emptying. To evaluate the safety and effectiveness of erythromycin or its derivatives in reducing symptoms and improving mechanical gastric emptying in adults diagnosed with gastroparesis. Our search included Medline and EMBASE databases. Literature in all languages were searched and translated to English. Clinical trials registers including the Cochrane Library, abstracts from major gastroenterology conferences and dissertations were also screened. Randomized controlled trials, quasi-randomized studies and experimental studies without randomization/allocation concealment were included in which Erythromycin or any other macrolide or its derivative is compared with a placebo in the treatment of gastroparesis. Quality of studies was evaluated using criteria of masking of randomization, masking of intervention, masking of outcome assessment and completeness of follow-up by review authors. Statistical methods included calculation of mean difference, standardized mean difference and odds ratio when appropriate. Ninety-five percent confidence interval was used for estimates of treatment effects. We are in the process of conducting a detailed analysis of the studies. From our preliminary analysis (21 studies, 717 patients), erythromycin and other derivatives do not significantly improve symptoms related to delayed gastric emptying when compared to a placebo within a 7–28 day period. Also, no significant differences were noted between erythromycin derivatives compared to placebo in reported serious adverse events. The general trend of studies showed significant improvement in mechanical emptying over 1–56 days, when erythromycin or its derivatives were compared to either placebo or metoclopramide. From the available literature it is evident that erythromycin and other derivatives improve gastric emptying. This has potential for exploration in specific subgroups of patients where mechanical improvement would offer improved outcomes (i.e. in patients who are mechanically ventilated to avoid aspiration). The trend in evidence for symptom improvement of gastroparesis does not favour erythromycin or other derivatives although a more formal and unified assessment is warranted. None
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.004 | 0.012 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.002 | 0.003 |
| Bibliometrics | 0.007 | 0.005 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.002 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.001 |
| Insufficient payload (model declined to judge) | 0.016 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".